Anti-PSGL-1 mAb produced a strong proinflammatory immune response across multiple tumors and tumor types by increasing cytokines involved in TME and T-cell activation as well as chemokines promoting immune cell infiltration (Fig. 6; Supplementary Fig. S8). The gene discussed is SELPLG; the disease is neoplasm.